Clinical Trial Update: Anti-ficolin-3 Autoantibodies in Lupus Nephritis

View source ↗

Summary

Clinical trial update on anti-ficolin-3 autoantibodies in lupus nephritis, a manifestation of systemic lupus erythematosus; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Lupus Erythematosus, Systemic | Status: COMPLETED